 |
 | Transplantation |
| |  | T Cell Subsets in Renal Transplant Rejection |
| | | HLA Typing with Matching of the Recipient and an Allograft Donor |
| | | Types of Transplant Rejection Based on the Time to Onset |
| Food Allergies |
| |  | Clinical Severity of Reaction in Food Allergy |
| | | Risk Factors for Severe Reaction in Peanut Allergy |
| | | Symptom Score of Verwimp et al for Cow's Milk Protein Intolerance in Infants |
| | | Grading Reaction Severity in Peanut and Nut Allergy |
| | | Recommendations of Bock et al for Reducing the Risk of a Food-Related Allergic Reaction in a School |
| | | Equations of Vanto et al for Predicting Tolerance to Milk By 4 Years of Age in an Infant with Cow's Milk Hypersensitivity |
| Antibody Production in the Central Nervous System |
| | | CSF-to-Serum Albumin Index and the Intactness of the Blood-Brain Barrier |
| | | CSF IgG-to-Albumin Ratio and CNS Production of Antibody |
| | | CSF-to-Serum IgG Index and CNS Production of Antibody |
| | | CSF IgG Index |
| | | CNS IgG Synthesis Rate |
| Chronic Fatigue Immune Dysfunction Syndrome |
| | | Criteria of Holmes et al for the Diagnosis of the Chronic Fatigue Immune Dysfunction Syndrome |
| | | Prognostic Factors of Hartz et al for Patients with the Chronic Fatigue Syndrome |
| | | Oxford Research Criteria for the Diagnosis of the Chronic Fatigue Syndrome |
| | | Criteria of Fukuda et al for Chronic Fatigue Syndrome (International Chronic Fatigue Syndrome Study Group) |
| | | Oxford Research Criteria for Post-Infectious Fatigue Syndrome (PIFS) |
| Quantitation of Immunoglobulins |
| | | Ratio of Kappa-to-Lambda Light Chains in the Serum |
| | | Relative Staining of Kappa-to-Lambda Light Chains in Bone Marrow Biopsies |
| Evaluation of Autoantibodies in Autoimmune Disorders |
| | | Patterns of Immunofluorescent Antinuclear Antibodies (ANA) |
| | | Clinical Indications for Measurement of Anti-Neutrophil Cytoplasmic Antibodies (ANCA) |
| Systemic Lupus Erythematosus (SLE) |
| | | Criteria for the Diagnosis of Systemic Lupus Erythematosus |
| | | Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) |
| | | SLICC/ACR Damage Index for Systemic Lupus Erythematosus |
| | | The Lupus Activity Criteria Count (LACC) |
| | | Systemic Lupus Activity Measure (SLAM) |
| | | Flare Severity Score of Lockshin et al for Patients with Systemic Lupus Erythematosus |
| | | The Activity Index of le Riche for Systemic Lupus Erythematosus |
| | | The Neonatal Lupus Syndromes |
| | | The SELENA Flare Tool |
| | | Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL) |
| | | Risk Factors for Drug-Induced Lupus Erythematosus |
| | | Management of a Patient with Drug-Induced Lupus Erythematosus |
| | | The European Consensus Lupus Activity Measurement (ECLAM) |
| | | Model of Ward et al for Predicting In-Hospital Mortality for a Patient with Systemic Lupus Erythematosus (SLE) |
| | | Clinical Features of Protein-Losing Enteropathy in a Patient with Systemic Lupus Erythematosus |
| Rheumatoid Arthritis |
| | | American Rheumatism Association (ARA) Criteria for the Diagnosis of Rheumatoid Arthritis |
| | | Classification Tree for Diagnosis of Rheumatoid Arthritis |
| | | Criteria for Complete Clinical Remission in Rheumatoid Arthritis |
| | | Felty's Syndrome |
| | | Criteria for Using Second Line Drugs in the Management of a Patient with Rheumatoid Arthritis |
| | | Criteria of Steinbrocker et al for Therapeutic Response in a Patient with Rheumatoid Arthritis |
| | | The Index of Mallya and Mace for Disease Activity in Rheumatoid Arthritis |
| | | Rheumatoid Arthritis Disease Activity Scores (DAS) of van der Heijde et al |
| | | Disease Activity Index of Scott for Evaluating Improvement Following Treatment of Rheumatoid Arthritis |
| | | Algorithm of Fehring and Brooks for Treatment of a Patient with Rheumatoid Arthritis and Neck Pain |
| | | Sakaguchi-Kauppi Method to Screen for Vertical Atlantoaxial Dislocation in a Patient with Rheumatoid Arthritis |
| | | The PIP Joint Synovitis Score for a Patient with Rheumatoid Arthritis |
| | | The Stoke Index of Davis et al for Measuring Disease Activity in a Patient with Rheumatoid Arthritis |
| | | Algorithm of Brennan et al for Predicting the Risk of Developing Radiological Erosions in a Patient with Early Rheumatoid Arthritis |
| | | Articular Index (AI) Score of Ritchie et al for a Patient with Rheumatoid Arthritis |
| | | Clinical Practice Decision Tree of the French Society of Rheumatology for the First Disease Modifying Antirheumatic Drug in Very Early Rheumatoid Arthritis |
| | | Decision Tree of Nell et al for Identifying the Risk of Developing Erosive Disease in a Patient with Early Arthritis |
| | | Disease Activity Score of Prevoo et al for Rheumatoid Arthritis Based on Separate 28 Joint Counts for Tender and Swollen Joints (DAS28, DAS28T+S) |
| | | The Index of Lansbury and Haut for Quantifying the Total Joint Inflammation and Deformity in a Patient with Rheumatoid Arthritis |
| | | Grades of Larsen for Radiographic Changes in Rheumatoid Arthritis |
| | | American College of Rheumatology Criteria for Improvement in Rheumatoid Arthritis Based on a 20 Percent Improvement in the Core Data Set (ACR20) |
| | | EULAR Therapeutic Response Criteria in a Patient with Rheumatoid Arthritis Based on the Change in DAS28 or DAS Scores |
| | | Model of Drossaers-Bakker et al for Identifying a Patient at Risk for Severe Rheumatoid Arthritis Within 12 Years Based on Baseline Parameters |
| | | Classification of Pellicci et al for Rheumatoid Arthritis Affecting the Cervical Spine |
| | | Indications of Bouchaud-Chabot and Liote for Surgery in a Patient with Rheumatoid Arthritis Involving the Cervical Spine |
| Polyarteritis Nodosa (PAN) |
| | | American College of Rheumatology (ACR) Criteria for Polyarteritis Nodosa |
| | | Classification Tree for the Diagnosis of Polyarteritis Nodosa |
| | | Criteria of Ozen et al for Diagnosis of Polyarteritis Nodosa in Childhood |
| | | Criteria for Polyarteritis Nodosa from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| | | Clinical Features of Polyarteritis Nodosa Associated with Viral Hepatitis B |
| Churg-Strauss Syndrome (Allergic Granulomatosis and Angiitis) |
| | | American College of Rheumatology (ACR) Criteria for the Diagnosis of Churg-Strauss Syndrome |
| | | Classification Tree for the Diagnosis of Churg-Strauss Syndrome |
| | | Criteria for Churg-Strauss Syndrome from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| | | Clinical Features of Churg-Strauss Syndrome |
| Wegener's Granulomatosis |
| | | American College of Rheumatology (ACR) Criteria fot the Diagnosis of Wegener's Granulomatosis |
| | | Classification Tree for the Diagnosis of Wegener's Granulomatosis |
| | | Histologic Diagnosis of Wegener's Granulomatosis Based on Biopsy from the Head and Neck |
| | | Criteria for a Major Exacerbation of Wegener's Granulomatosis |
| | | Disease Activity Index for Wegener's Granulomatosis |
| | | Histopathologic Findings of Matsubara et al in a Nasal Biopsy from a Patient with Wegener's Granulomatosis |
| | | Criteria for Wegener's Granulomatosis from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| | | Prognostic Features for a Patient with Wegener's Granulomatosis |
| | | Prognostic Factors of Slot et al for a Patient with PR3-ANCA Associated Vasculitis with Renal Involvement |
| | | Clinical and Laboratory Findings Associated with Wegener's Granulomatosis |
| | | Criteria for Limited Wegener's Granulomatosis from the Wegener's Granulomatosis Etanercept Trial |
| | | ELK Classification of DeRemee et al for Wegener's Granulomatosis |
| | | Modified ELK Score of Reinhold-Keller et al for Describing the Extent of Wegener's Granulomatosis |
| Temporal (Giant Cell) Arteritis and Polymyalgia Rheumatica |
| | | American College of Rheumatology (ACR) Criteria for the Diagnosis of Temporal (Giant Cell) Arteritis |
| | | Classification Tree for the Diagnosis of Temporal (Giant Cell) Arteritis |
| | | Criteria of Chuang et al for Polymyalgia Rheumatica |
| | | Criteria of Healey for Polymyalgia Rheumatica |
| | | Criteria for Large Vessel Vasculitis (Giant Cell vs Takayasu Arteritis) from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| | | Criteria of Bird et al for Polymyalgia Rheumatica |
| | | Risk Factors of Larsson et al for Giant Cell Arteritis in Women |
| | | Algorithm of Shmerling for a Patient with Possible Temporal Arteritis |
| | | Risk Factors of Nesher et al for Cranial Ischemic Complications in a Patient with Giant Cell Arteritis |
| | | Clinical Features of Temporal (Giant Cell Arteritis |
| | | Temporal Artery Biopsy Formula of Younge et al |
| Hypersensitivity Vasculitis and Cutaneous Leukocytoclastic Angiitis |
| | | American College of Rheumatology (ACR) Criteria for the Diagnosis of Hypersensitivity Vasculitis |
| | | Classification Tree for the Diagnosis of Hypersensitivity Vasculitis |
| | | Criteria for Cutaneous Leukocytoclastic Angiitis from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| Henoch-Schonlein Purpura |
| | | American College of Rheumatology (ACR) Criteria for the Diagnosis of Henoch-Schonlein Purpura |
| | | Classification Tree for the Diagnosis of Henoch-Schonlein Purpura |
| | | Criteria for Henoch-Schonlein Purpura from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| Takayasu Arteritis |
| | | American College of Rheumatology (ACR) Criteria for the Diagnosis of Takayasu Arteritis |
| | | Classification Tree for the Diagnosis of Takayasu Arteritis |
| | | Criteria of Ishikawa for the Diagnosis of Takayasu Arteritis |
| | | Criteria of Sharma et al for the Diagnosis of Takayasu Arteritis |
| | | Criteria of Kerr et al for Active Takayasu Arteritis |
| Behcet's Disease |
| | | Criteria for the Diagnosis of BehcetÕs Disease from the International Study Group for BehcetÕs Disease |
| | | Diagnostic Criteria for BehcetÕs Syndrome from the BehcetÕs Disease Research Committee of Japan |
| | | Additional Clinical and Laboratory Findings in BehcetÕs Disease |
| | | Behcet's Disease Activity Index of Lawton et al |
| Acute Graft versus Host Disease (GVHD) |
| | | Clinical Stage and Grade of Acute GVHD by Glucksberg et al |
| | | International Bone Marrow Transplant Registry (IBMTR) Severity Index for Grading Acute Graft versus Host Disease |
| | | Histopathologic Grading of Acute Graft versus Host Disease |
| | | Acute Graft versus Host Activity Index (aGVHDAI) of Leisenring et al |
| | | Prognostic Factor Score of Akpek et al for a Patient with Chronic Graft-versus-Host Disease (GVHD) |
| Sjogren's Syndrome |
| | | Criteria for the Diagnosis of Sjogren's Syndrome |
| | | Histologic Grading of a Labial Salivary Gland Biopsy in Patients with Sjogren's Syndrome |
| | | Criteria of Fox et al for Sjogren's Syndrome (La Jolla or California Criteria) |
| | | Criteria of Homma et al for Sjogren's Syndrome (Japanese Ministry of Health and Welfare) |
| | | Criteria of Segerberg-Konttinen et al for Sjogren's Syndrome |
| | | Criteria of Skopouli et al for Sjogren's Syndrome (Greek Criteria) |
| | | Criteria of Manthorpe et al for Sjogren's Syndrome (Copenhagen Criteria) |
| | | Criteria of Vitali et al for Sjogren's Syndrome (Preliminary European Criteria) |
| | | Classification Tree of Vitali et al for Primary Sjogren's Syndrome |
| | | Exclusion Conditions in the Diagnosis of Sjogren's Syndrome |
| | | Sjogren's Syndrome Disease Damage Index (SSDDI) |
| | | Sjogren's Syndrome Disease Activity Index (SSDAI) |
| Systemic Vasculitis |
| | | Systemic Necrotizing Vasculitis Damage Index (SNVDI) |
| | | The French Five Factor Score (FFS) |
| | | Criteria of Shionoya for Thromboangiitis Obliterans (TAO, Buerger's Disease) |
| | | Vasculitis Associated with Cocaine or Amphetamine Abuse, Including Pseudo-Wegener's Granulomatosis |
| | | Differential Diagnosis of a Pulmonary-Renal Vasculitic Syndrome |
| | | Clinical Features of Degos Syndrome (Malignant Atrophic Papulosis, Lymphocytic Arteriolitis) |
| | | Clinical and Laboratory Features of Schnitzler's Syndrome |
| | | Criteria of Lipsker et al for Schnitzler's Syndrome |
| | | Criteria of Scott and Bacon for Systemic Rheumatoid Vasculitis |
| | | Differential Diagnosis of Small Vessel Vasculitis |
| | | Clinical Classification of the European Vasculitis Study Group (EVSG) for the Disease Severity of an ANCA-Associated Vasculitis |
| | | Causes of Pseudovasculitis |
| Spondylarthropathies, Including Postinfectious Seronegative Arthropathies and Ankylosing Spondylitis |
| | | Criteria for Reiter's Syndrome |
| | | Screening Questionnaire for Ankylosing Spondylitis |
| | | Rome Criteria for Ankylosing Spondylitis |
| | | New York Criteria for Ankylosing Spondylitis |
| | | Modified New York Criteria for Ankylosing Spondylitis |
| | | Criteria of Amor et al for Spondylarthropathy |
| | | The European Spondylarthropathy Study Group (ESSG) Criteria for Spondylarthropathy |
| | | Prediction of Longterm Outcome in Spondyloarthropathy Using the Score of Amor et al |
| | | Disease Activity Index for Reactive Arthritis (DAREA) |
| | | Criteria of Creemers et al for Active Disease in Ankylosing Spondylitis |
| | | Ankylosing Spondylitis Disease Activity Score (AS-DAS) of Creemers et al |
| | | Articular Index of Dougados et al for Patients with Ankylosing Spondylitis |
| | | Criteria of the Ankylosing Spondylitis Working Group for Clinical Remission |
| | | Criteria of the Ankylosing Spondylitis Working Group for Clinical Response to Therapy |
| | | Bath Ankylosing Spondylitis Functional Index (BASFI) |
| | | Mander Enthesis Index (MEI) in Ankylosing Spondylitis |
| | | Reduced Mander Enthesis Index of Heuft-Dorenbosch et al for Ankylosing Spondylitis |
| | | Concise Enthesis Index of Heuft-Dorenbosch et al for Ankylosing Spondylitis (Maastrich Ankylosing Spondylitis Enthesitis Score, MASES) |
| | | Criteria of Sieper and Braun for Reactive Arthritis |
| | | Criteria of the Deutschen Gesellschaft fur Rheumatologie for Reactive Arthritis |
| | | Stoke Ankylosing Spondylitis Spine Score (SASSS) |
| | | Bath Ankylosing Spondylitis Radiology Index (BASRI, BASRI-s) |
| | | MRI Chronicity Index and Activity Index of Bollow et al in a Patient with Sacroiliitis |
| | | Bath Anklyosing Spondylitis Metrology Index (BASMI) |
| | | Modified Schober Index of Macrae and Wright for Measuring Back Flexion |
| | | Early Diagnostic Criteria of Mau et al for Ankylosing Spondylitis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for Juvenile Enthesitis-Related Arthritis |
| | | Prognostic Factors of Leirisalo-Repo for Reactive Arthritis and the Spondyloarthropathies |
| | | Edmonton Ankylosing Spondylitis Metrology Index (EDASMI) |
| | | Clinical Features of Arthritis Associated with Ulcerative Colitis |
| | | Criteria of Rudwaleit et al for Inflammatory Back Pain in a Young to Middle-Aged Adult with Chronic Back Pain |
| Systemic Sclerosis (Scleroderma) |
| | | ARA Scleroderma Criteria Cooperative Study Preliminary Clinical Criteria for Systemic Sclerosis |
| | | Hidebinding/Tethering Skin Score of Furst et al for Scleroderma |
| | | Rodnan Score for Progressive Systemic Sclerosis |
| | | Modified Rodnan Skin Score in Scleroderma Using 17 Sites |
| | | Modified Rodnan Skin Score in Scleroderma Using 5 Sites |
| | | Organ System Indices of Furst et al in Systemic Sclerosis |
| | | Kahaleh Skin Score in Scleroderma |
| | | Risk Factors for Scleroderma Renal Crisis |
| | | Risk Model of Bryan et al for 5 Year Survival in a Patient with Scleroderma |
| | | Criteria of Valentini et al (European Scleroderma Study Group) for Systemic Sclerosis |
| | | Criteria of Valentini et al (European Scleroderma Study Group) for Diffuse and Limited Systemic Sclerosis |
| | | Criteria of Steen et al for Scleroderma Renal Crisis |
| | | Classification of Maricq for Changes Seen in the Fingernail Capillaries of a Patient with Scleroderma |
| | | Nailfold Capillary Microscopic Profiles of Joyal et al in a Patient with Systemic Sclerosis |
| | | Criteria of LeRoy and Medsger for Limited Forms of Systemic Sclerosis (lSSc) |
| | | Criteria of LeRoy and Medsger for Limited Cutaneous (lcSSc, CREST Syndrome) or Diffuse Cutaneous Systemic Sclerosis (dcSSc) |
| | | Clinical Features of Occupation-Related Scleroderma |
| | | Criteria of Lally et al for Rapidly Progressive (Fulminant) Progressive Systemic Sclerosis |
| | | Clinical Findings Associated with Involvement of the Esophagus or Stomach in Systemic Sclerosis |
| | | Presenting Symptoms of Progressive Systemic Sclerosis |
| | | Criteria of the PRES/ACR/EULAR for the Diagnosis of Juvenile Systemic Sclerosis |
| Dermatomyositis, Polymyositis and Idiopathic Inflammatory Myositis |
| | | Classification Criteria of Tanimoto et al for Polymyositis and Dermatomyositis |
| | | Prognostic Factors of Benbassat et al for a Patient with Polymyositis or Dermatomyositis |
| | | Criteria of Bohan and Peter for the Diagnosis of Polymyositis and Dermatomyositis |
| | | Overlap Syndrome in a Patient with Dermatomyositis |
| | | Criteria of Marie et al for Remission of Polymyositis or Dermatomyositis |
| | | Prognostic Factors of Marie et al for a Patient with Polymyositis or Dermatomyositis |
| | | Prognostic Factors of Maugars et al for a Patient with Dermatomyositis or Polymyositis |
| Angioedema |
| | | Staging the Airway Risk in a Patient with Angioedema |
| | | Triage Algorithm for a Patient with Angioedema of the Head and Neck |
| | | Types of Angioneurotic Edema |
| | | Risk Factors of Kostis et al for Enalapril-Induced Angioedema |
| | | Classification of Kostis et al for the Severity Angioedema Based on Treatment Intensity |
| | | Criteria of Agostini et al for the Diagnosis of Angioedema Associated wtih a Deficiency of C1-Inhibitor |
| | | Criteria of Agostoni et al for Determining the Severity of Hereditary Angioedema |
| | | Angioedema Associated with Estrogen Excess |
| Laboratory Tests of Cell-Mediated and Humoral Immunity |
| | | Thymidine Incorporation by Lymphocytes and the Stimulation Index (SI) |
| | | Lymphocyte Cytotoxicity (LCT) Assay for Detecting Antibodies to HLA Antigens |
| Myasthenia Gravis |
| | | Clinical Classification of Osserman and Genkins for Myasthenia Gravis |
| | | Clinical Crisis in Patients with Myasthenia Gravis |
| | | Predictors of Favorable Response to Thymectomy in Patients with Myasthenia Gravis |
| | | Prognostic Factors of Tellez-Zenteno et al in Patients with Myasthenia Gravis Following Thymectomy |
| | | Clinical Distinction of Myasthenia Gravis from Lambert-Eaton Myasthenic Syndrome |
| | | Clinical Classification of the Myasthenia Gravis Foundation of America (MGFA) for Myasthenia Gravis |
| | | Clinical Score of Besinger et al for a Patient with Myasthenia Gravis |
| | | Ice Pack Test for Evaluating a Patient with Ptosis |
| Latex Allergy |
| | | Risk Factors for a Person Having a Latex Allergy |
| | | Clinical Features of Latex Allergy in an Infant |
| Psoriatic Arthritis |
| | | Criteria of Bennett for the Diagnosis of Psoriatic Arthritis |
| | | Risk Factors of Gladman et al for Mortality in Patients with Psoriatic Arthritis |
| | | Classification of Moll and Wright for Psoriatic Arthritis |
| | | Risk Factors of Gladman et al for Identifying a Patient at Diagnosis of Psoriatic Arthritis Who Is at Risk for Disease Progression |
| | | Tool of Helliwell et al for Evaluating Dactylitis in a Patient with Psoriatic Arthritis |
| | | Criteria of Southwood et al for the Diagnosis of Juvenile Psoriatic Arthritis (Vancouver Criteria) |
| | | Criteria for the Diagnosis of Psoriatic Arthritis of the CASPAR Investigators |
| | | Criteria of Vasey and Espinoza for Psoriatic Arthritis |
| | | Modified Criteria of McGonagle et al for the Diagnosis of Psoriatic Arthritis |
| | | Criteria of Fournie et al for Psoriatic Arthritis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for Juvenile Psoriatic Arthritis |
| | | Score of Wassenberg et al for Radiographic Changes in a Patient with Psoriatic Arthritis |
| Allergic Rhinitis |
| | | Allergic Rhinitis Severity Score of Lunn et al |
| | | Score for Allergic Rhinitis (SFAR) of Annesi-Maesano et al |
| | | Allergic Rhinitis Severity Score of Berges-Gimeno et al |
| | | Classification of Bousquet et al for Allergic Rhinitis |
| | | Total Nasal Symptom Score (TNSS), Cough Score and Overall Symptom Score of Gawchik et al for a Patient with Allergic Rhinitis |
| Evaluation of the Patient with Arthritis |
| | | Model of Visser et al for Early Prediction of Outcome in Patients with Arthritis |
| | | Synovialitis Score of Krenn et al for Grading Histologic Features of Chronic Synovitis |
| | | Tool of Len et al for Identifying a Pediatric Patient with Chronic Arthropathy Who Should Be Referred to a Rheumatologist |
| | | Prediction Rule of van der Helm-van Mil et al for Evaluating a Patient with a Recent Onset of Undifferentiated Arthritis |
| | | Clinical Features of Parvovirus B19-Associated Arthropathy |
| Immunodeficiency States |
| | | Evaluation of the Immune Status in a Patient With Bacterial Meningitis or Invasive Bacterial Infection |
| | | Clinical Features of the X-Linked Hyper-IgM Syndrome |
| | | Clinical Features of the Wiskott-Aldrich Syndrome (WAS) |
| | | Clinical Features of Hyper-IgE Syndrome (HIES, Job Syndrome) |
| Physical Urticaria |
| | | Solar Urticaria |
| | | Aquagenic Urticaria and Aquagenic Pruritis |
| | | Cholinergic Urticaria (Generalized Heat-Induced Urticaria) |
| | | Dermographism (Dermatographism) |
| Autoimmune Hemolytic Disease Due to Warm or Cold Agglutinins |
| | | Separating a Significant Cold Agglutinin from a Laboratory Annoyance |
| Generalized Hypersensitivity, Anaphylaxis and Anaphylactoid Reactions |
| | | Indications for a Patient to Carry an Epinephrine (Adrenaline) Auto-Injector |
| | | Grades of Laxenaire for the Severity of an Anaphylactoid Reaction |
| | | Grading System of Brown for a Generalized Hypersensitivity Reaction |
| | | Risk Factors of Brown for Hypoxia in a Patient with a Generalized Hypersensitivity Reaction |
| | | Risk Factors of Brown for Hypotension in a Patient with a Generalized Hypersensitivity Reaction |
| | | Impact of Beta-Adrenergic Blocking Agents on a Patient with Anaphylaxis |
| Allergic Contact Dermatitis |
| | | Clinical Features of a Systemic Allergic Contact Dermatitis Reaction |
| | | Systemic Allergic Contact Dermatitis with a Bathing Trunk Distribution (Baboon Syndrome) |
| | | Grading Scale of Williams et al for Uroshiol Contact Dermatitis Following Exposure to Poison Ivy or Poison Oak |
| | | Clinical Features of Metal Sensitivity in a Patient with an Orthopedic Implant |
| | | Clinical Features of Mercury Sensitivity Associated with Dental Amalgam |
| | | Clinical Features of Nickel Sensitivity |
| | | Contact Allergic Reactions Following Exposure to Smoke from Burning Poison Ivy or Poison Oak |
| | | Contact Allergic Dermatitis to Lacquer (Sap of the Rhus Tree) |
| | | Systemic Allergic Dermatitis Following Oral Intake of Urushiol from the Rhus Tree as an Herbal Medicine |
| | | Contact Allergic Dermatitis to Mango |
| | | Contact Allergic Dermatitis to the Fruit of the Ginkgo Tree |
| | | Contact Allergy to Polyvinylpyrrrolidone, Including Povidone-Iodine |
| Cryoglobulinemia and Cryoproteins |
| | | Types of Brouet et al for Cryoglobulins |
| | | Clinical Findings in a Patient with Cryoglobulinemia |
| | | Reasons for Failure to Detect a Cryoglobulin |
| | | Clinical Findings in a Patient with Cryofibrinogen |
| | | Criteria for Essential Cryoglobulinemic Vasculitis from the International Consensus Conference on the Nomenclature of Systemic Vasculitis (Chapel Hill Conference) |
| Goodpasture's Disease and Syndrome |
| | | Clinical Features of Goodpasture's Disease |
| | | Differential Diagnosis of Goodpasture's Syndrome |
| | | Risk Factors for Exacerbation of Goodpasture's Disease |
| Systemic Sarcoidosis |
| | | Lofgren's Syndrome |
| | | Clinical Features Associated with an Acute vs Chronic Course in Systemic Sarcoidosis |
| | | Indications for Oral Corticosteroid Therapy in a Patient with Sarcoidosis |
| | | Criteria of Mana for Disease Activity in Sarcoidosis |
| | | Criteria of Judson et al for the Diagnosis of Cardiac Sarcoidosis |
| | | Method of Judson for Assessity the Clinical Severity of Sarcoidosis |
| Skin Testing for Detection of Allergy |
| | | Causes of a Misleading Allergen Skin Test |
| Retroperitoneal Fibrosis |
| | | Clinical Findings in Retroperitoneal Fibrosis |
| | | Causes of Retroperitoneal Fibrosis |
| | | Algorithm of Vaglio et al for the Management of a Patient with Retroperitoneal Fibrosis |
| Adult Still's Disease |
| | | Criteria of the Japanese Adult Still's Disease Research Committee for Adult Still's Disease |
| Juvenile Arthritis |
| | | Criteria of the Pediatric Rheumatology International Trials Organization (PRINTO) for Improvement in Juvenile Arthritis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for Idiopathic Juvenile Oligoarthritis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for Idiopathic Juvenile Polyarthritis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for Idiopathic Juvenile Systemic Arthritis |
| | | ILAR (International League of Assocations for Rheumatology) Criteria for "Other" Juvenile Arthritis |
| | | The Pediatric Escola Paulista de Medicina Range of Motion (EPM-ROM) Scale for Juvenile Rheumatoid Arthritis |
| | | American Rheumatism Association (ARA) Criteria for Juvenile Rheumatoid Arthritis |
| SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) Syndrome |
| | | Criteria of Chamot et al for the SAPHO Syndrome |
| Mixed Connective Tissue Disease (MCTD) |
| | | Criteria of Alarcon-Segovia and Villareal for the Diagnosis of Mixed Connective Tissue Disease |
| | | Criteria of Sharp for the Diagnosis of Mixed Connective Tissue Disease |
| | | Criteria of Kasukawa et al for the Diagnosis of Mixed Connective Tissue Disease |
| | | Discriminant Function of Ishikawa et al for Distinguishing Mixed Connective Tissue Disease from Progressive Systemic Sclerosis |
| Hereditary Periodic Fever and Autoinflammatory Disease |
| | | Diagnostic Criteria of Scully et al for Familial Mediterranean Fever |
| | | Clinical Features of the Hyper-IgD Syndrome |
| | |